Evidence map›Paper›PMID 36791754›Full record

Trial reportJournal of the National Comprehensive Cancer Network : JNCCN2023

Effect of Yoga and Mediational Influence of Fatigue on Walking, Physical Activity, and Quality of Life Among Cancer Survivors.

Po-Ju Lin, Brian J Altman, Nikesha J Gilmore, Kah Poh Loh, Richard F Dunne, Javier Bautista, Chunkit Fung, Michelle C Janelsins, Luke J Peppone, Marianne K Melnik and 3 more

Open access · bronzeAbstract readRandomized Controlled TrialMulticenter StudyClinical Trial, Phase III
In one paragraph

Trial report in Journal of the National Comprehensive Cancer Network : JNCCN, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Yoga for fatigue in people with cancer.The Cochrane database of systematic reviews · 2025
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Po-Ju LinDepartment of Surgery, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
Brian J AltmanDepartment of Biomedical Genetics, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
Nikesha J GilmoreDepartment of Surgery, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
Kah Poh LohDepartment of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
Richard F DunneDepartment of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
Javier BautistaDepartment of Mathematics, University of Rochester, Rochester, New York.
Chunkit FungDepartment of Medicine, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
Michelle C JanelsinsDepartment of Surgery, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
Luke J PepponeDepartment of Surgery, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
Marianne K MelnikCancer Research Consortium of West Michigan NCORP, Grand Rapids, Michigan.
Kim O GococoNCORP of the Carolinas (Greenville Health System), Greenville, South Carolina.
Michael J MessinoSoutheast Clinical Oncology Research Consortium NCORP, Winston Salem, North Carolina.
Karen M MustianDepartment of Surgery, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.
University of Rochester Medical Center · USMichigan Cancer Research Consortium · USPrisma Health · USSoutheast Clinical Oncology Research Consortium · USUniversity of Rochester · US

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
UNIVERSITY OF ROCHESTER--CCOP RESEARCH BASEU10CA037420 · NCI · UNIVERSITY OF ROCHESTER · PI MORROW, GARY R · 1985 to 2014
$21.1M
Yoga Versus CBT-I for Insomnia in Cancer Survivors and Biobehavioral MechanismsR01CA181064 · NCI · UNIVERSITY OF ROCHESTER · PI MUSTIAN, KAREN M. · 2014 to 2019
$3.1M
Clinical and Translational Cancer Control Research Training ProgramT32CA102618 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, Gary R Morrow · 2019 to 2026
$2.7M
NCI NIH HHS R01 CA181064NCI NIH HHS T32 CA102618NCI NIH HHS U10 CA037420NCI NIH HHS UG1 CA189961
6 · The paper itself

Abstract

backgroundCancer-related fatigue (CRF) negatively affects survivors' walking, engagement in physical activity (PA), and quality of life (QoL). Yoga is an effective therapy for treating CRF; however, evidence from large clinical trials regarding how reducing CRF through yoga influences CRF's interference with survivors' walking, engagement in PA, and QoL is not available. We examined the effects of yoga and the mediational influence of CRF on CRF's interference with walking, PA, and QoL among cancer survivors in a multicenter phase III randomized controlled trial. PATIENTS AND

methodsCancer survivors (n=410) with insomnia 2 to 24 months posttreatment were randomized to a 4-week yoga intervention-Yoga for Cancer Survivors (YOCAS)-or standard care. A symptom inventory was used to assess how much CRF interfered with survivors' walking, PA, and QoL. The Multidimensional Fatigue Symptom Inventory-Short Form was used to assess CRF. Two-tailed t tests and analyses of covariance were used to examine within-group and between-group differences. Path analysis was used to evaluate mediational relationships between CRF and changes in CRF's interference with walking, PA, and QoL among survivors.

resultsCompared with standard care controls, YOCAS participants reported significant improvements in CRF's interference with walking, PA, and QoL at postintervention (all effect size = -0.33; all P≤.05). Improvements in CRF resulting from yoga accounted for significant proportions of the improvements in walking (44%), PA (53%), and QoL (45%; all P≤.05).

conclusionsA significant proportion (44%-53%) of the YOCAS effect on CRF's interference with walking, PA, and QoL was due to improvements in CRF among cancer survivors. Yoga should be introduced and included as a treatment option for survivors experiencing fatigue. By reducing fatigue, survivors further improve their walking, engagement in PA, and QoL.

Indexed as

Cancer SurvivorsNeoplasmsYogaExerciseFatigueHumansQuality of LifeWalkingCancer-related FatiguePhysical Activityquality of lifeSurvivorshipYoga

Identifiers

PMID36791754
PMCPMC9990873
OpenAlexW4320932484

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.